agonists , 4 OH-GTS-21 and S 24795

One approach for the identification of therapeutic agents for Alzheimer’s disease has focused on the research of a7 nAChR-selective agonists such as the partial agonists 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) and, more recently, 2-[2-(4-bromophenyl)-2-oxoethyl]-1methyl pyridinium (S 24795). An alternative approach for targeting a7 nAChR… (More)